Ledipasvir/sofosbuvir ± ribavirin for 12 or 24 weeks is safe and effective in children 6–11 years old with chronic hepatitis C infectionK.F. Murray, W. Balistreri,S. Bansal, S. Whitworth,H. Evans, R.P. Gonzalez-Peralta,J. Wen,B. Massetto,K. Kersey,Y. Zhu,K. Garrison,E. Svarovskaia,D.M. Brainard,R. Arnon,L. Gillis,M.M. Jonas,C.-H. Lin,M.R. Narkewicz, K. Schwarz,P. RosenthalJOURNAL OF HEPATOLOGY（2017）引用 11|浏览57暂无评分AI 理解论文溯源树样例生成溯源树，研究论文发展脉络Chat Paper正在生成论文摘要
